Corporate News

CNSL (AIM: CNSL), the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health, announces its audited results for the year ended 31 March 2026, a year that has seen the establishment of a robust foundation for the future after transitioning out of a diverse group structure.

Financial highlights

• Revenues of £7.0m (2025| £8.3m) – decline due to challenging market conditions which necessitated some internal restructuring
• Gross margin rose by 3.8% to 67.8% (2025 | 65.3%)
• Adjusted EBITDA* fell to a loss of £0.4m (2025 | profit of £0.4m)
• Profit before taxation fell to a loss of £4.4m after £3m goodwill impairment (2025: profit of £1.6m (Stated after net exceptional income of £1.8m)
• Cash and deposits of £2.6m (2025: £4.9m)

Operational highlights

• CNSLab productivity CNSLab have successfully implemented a new Laboratory Information Management System, further driving up productivity and consistently beating turnaround times
• Product yields Production yields have further improved from 52% to 65%, increasing capacity and reducing costs
• Funding Remains sufficiently funded for IVDR project and future growth
• New sales structure New Global Sales Director appointed and a new Customer Success Team implemented to drive partner growth

*Adjusted for exceptional items and share based payment charges.

Carolyn Rand, Chair of CNSL, comments "While the global market threw its fair share of challenges our way this year, it also revealed the true resilience of our business. By streamlining our operations, strengthening our leadership, and deepening our support for global partners, we haven’t just navigated a difficult backdrop - we’ve built a leaner, sharper, and more competitive CNS. We are entering the new year on a much stronger footing, ready to turn immense potential into tangible growth."

Contacts

Cambridge Nutritional Sciences plc | cnspl.com | investors@cnsplc.com

James Cooper | Chief Executive Officer

Ajay Patel | Chief Financial Officer

Cavendish Capital Markets Ltd | Geoff Nash / Edward Whiley (Corporate Finance)

Nigel Birks / Harriet Ward (ECM) | 020 7220 0500

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health.